home > research & development > xenoport pipeline
Our current portfolio of proprietary product candidates includes the following:
Research and Development Home
XenoPort Pipeline
Gabapentin Enacarbil
Arbaclofen Placarbil
XP21279
Preclinical Candidates
Our Technology
The U.S. National Institutes of Health provides a Web site of many current and past clinical trials. To view information about XenoPort’s clinical trials, please go to www.clinicaltrials.gov.
This icon indicates a link to an external site.
Terms and Conditions | Privacy